Antimicrobial peptides versus parasitic infections?
Reports of antimicrobial peptides generally have evaluations of their antibacterial and antifungal activities. By contrast, little is known of their activities against protozoan and metazoan parasites. In vitro antiparasitic assays suggest that antimicrobial peptides could represent a powerful tool for the development of novel drugs to fight the parasite in the vertebrate host, or to complement current therapeutic strategies.
Vizioli
Jacopo
J
Salzet
Michel
M
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000962:Antimalarials / Q000494:pharmacology; D006801:Humans; D007891:Leishmania; D007896:Leishmaniasis / Q000188:drug therapy*; D008288:Malaria / Q000188:drug therapy*; D010455:Peptides; D010961:Plasmodium
D000900:Anti-Bacterial Agents; D000962:Antimalarials; D010455:Peptides